Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer.
Nishimura J, Hasegawa J, Kato T, Yoshioka S, Noura S, Kagawa Y, Yasui M, Ikenaga M, Murata K, Hata T, Matsuda C, Mizushima T, Yamamoto H, Doki Y, Mori M; Clinical Study Group of Osaka University (CSGO) Colorectal Group.
Nishimura J, et al. Among authors: kato t.
Cancer Chemother Pharmacol. 2018 Oct;82(4):707-716. doi: 10.1007/s00280-018-3663-z. Epub 2018 Aug 4.
Cancer Chemother Pharmacol. 2018.
PMID: 30078098
Clinical Trial.